worldwide offices | stay connected | contact | help | sitemap

 
 

 

 

 

Feature story

Joining forces against the new wave of tuberculosis

Joining forces against the new wave of tuberculosis

Once thought a disease of the past, tuberculosis is again becoming an international health threat... more ›

Our products

We want to improve your quality of life.

 

Latest news

07-Oct-2008
New Phase II data on NVA237, a novel once-daily treatment for COPD, show promising efficacy and tolerability with potentially faster onset than tiotropium

06-Oct-2008
New study shows potential benefits of innovative Xolair® anti-IgE therapy in treating children suffering from moderate-to-severe allergic asthma

30-Sep-2008
Once-yearly Aclasta® approved in EU to treat osteoporosis in men and to reduce risk of new fractures following hip fracture both in men and postmenopausal women

Investors

 
 

NOVZn

 

 
 

NVS

 

 
Worldwide Sites

USA • Switzerland • Germany • France • United Kingdom

 

Super Sector Leader

Super Sector Leader

Novartis is the 2008 super sector leader in healthcare for the Dow Jones Sustainability Index (DJSI).

Read more on the Citizenship@Novartis website

Careers

Novartis careers

Our success depends on the creativity and performance of our associates.

Learn more about working at Novartis